Pfizer's Lipitor share slips, casting doubt on power of a loyalty program to save the brand
January 25 2012
Seven weeks after Pfizer's main Lipitor patent expired in the US, the drug is down to 32% market share and ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.